Bladder Training Supported by Alarm Reminders and Distraction Techniques for Mixed Urinary Incontinence
ARDT-MUI
Effectiveness of Bladder Training Supported by Alarm Reminders and Distraction Techniques in Women With Persistent Mixed Urinary Incontinence Following Pelvic Floor Muscle Exercise Therapy: A Randomized Controlled Trial
1 other identifier
interventional
111
1 country
1
Brief Summary
This randomized controlled trial evaluated the effectiveness of bladder training supported by smartphone alarm reminders and distraction techniques in women with persistent mixed urinary incontinence who continued to experience symptoms despite completing pelvic floor muscle exercise (PFME) therapy at least six months previously. Participants were stratified according to age, educational level, body mass index, mode of delivery, and baseline urinary incontinence severity before randomization to either an intervention group or a control group. The intervention group received an 8-week bladder training program supported by alarm reminders and distraction techniques, while the control group received routine care. Outcomes included urinary incontinence severity, symptom distress, quality of life, urinary incontinence episodes, voiding intervals, treatment satisfaction, and adherence to bladder training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2022
CompletedFirst Submitted
Initial submission to the registry
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 8, 2026
CompletedJuly 10, 2026
July 1, 2026
6 months
July 1, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary Incontinence Severity
Urinary incontinence severity was assessed using the Incontinence Severity Index (ISI). Higher scores indicate greater urinary incontinence severity.
Baseline and Week 8
Secondary Outcomes (1)
Objective Urine Loss
Baseline and Week 8
Other Outcomes (1)
Urinary Symptom Distress
Baseline and Week 8
Study Arms (2)
Bladder Training Supported by Alarm Reminders and Distraction Techniques
EXPERIMENTALParticipants received an individualized 8-week bladder training program supported by smartphone alarm reminders and distraction techniques. The intervention included pelvic floor muscle contractions, urgency suppression strategies, timed voiding with gradually increasing voiding intervals, smartphone alarm reminders, and bead-counting distraction techniques.
Routine Outpatient Care
ACTIVE COMPARATORParticipants received routine outpatient follow-up care without structured bladder training during the study period. After completion of data collection, educational materials and distraction objects were provided.
Interventions
Participants received an individualized 8-week bladder training program supported by smartphone alarm reminders and distraction techniques. The intervention included pelvic floor muscle contractions, urgency suppression strategies, timed voiding with gradually increasing voiding intervals, smartphone alarm reminders, and bead-counting distraction techniques.
Participants received routine outpatient follow-up care without structured bladder training during the study period.
Eligibility Criteria
You may qualify if:
- Women aged 18-65 years.
- Physician-diagnosed mixed urinary incontinence.
- Previously received pelvic floor muscle exercise (PFME) as the sole treatment for urinary incontinence.
- Completed PFME therapy at least six months before enrollment.
- Continued to experience urinary incontinence symptoms after completion of PFME therapy.
- Owned and were able to use a smartphone.
- Were not receiving any active treatment for urinary incontinence during the study period.
- Provided written informed consent.
You may not qualify if:
- Urinary tract infection.
- Neurological disorders affecting bladder function.
- Pregnancy.
- Active treatment for urinary incontinence.
- Previous bladder training.
- Previous biofeedback therapy.
- Previous magnetic chair therapy.
- Cognitive impairment.
- Any medical condition that could interfere with participation or completion of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Katip Celebi University Ataturk Training and Research Hospital
Izmir, İzmir, 35620, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Perihan Çetin
Izmir Katip Celebi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This was an open-label trial because participants and investigators were aware of group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 1, 2026
First Posted
July 8, 2026
Study Start
June 15, 2022
Primary Completion
December 15, 2022
Study Completion
December 15, 2022
Last Updated
July 10, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available because the informed consent obtained from participants did not include permission for public data sharing. De-identified data may be made available from the corresponding author upon reasonable request and subject to institutional ethics approval and applicable regulations.